PATRICK G LEPORE
CIK 1055404 · Executive Chairman · last filed 2025-12-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.67M
Companies
6
Total Filings
79
Lifetime Open-Market Net
$966.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | Director | 51,472 | $0.65 | $33.4K | $399.9K | 15 | 2025-12-15 |
| LANNETT CO INC (LCI) Delisted | Director | 587,145 | $0.69 | $402.5K | $1.65M | 16 | 2022-11-14 |
| MTNB | Director | 400,000 | $0.78 | $312.0K | $345.7K | 8 | 2020-11-10 |
| PharMerica CORP (PMC) Delisted | Director | 0 | — | — | $0 | 7 | 2017-12-08 |
| INVA | Director | 58,278 | $22.74 | $1.33M | $0 | 2 | 2017-04-24 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Chairman and CEO | 214,793 | — | — | -$1.43M | 30 | 2012-01-13 |
Recent Filings · Page 6 of 8
79 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-11 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −5,365 | -$188.3K | EDGAR |
| 2012-01-06 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −2,941 | -$94.6K | EDGAR |
| 2011-09-07 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Buy (P) | +8,000 | $207.4K | EDGAR |
| 2011-08-10 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −8,690 | -$252.8K | EDGAR |
| 2011-05-11 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Mixed | — | -$1.38M | EDGAR |
| 2011-03-24 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −2,455 | -$71.2K | EDGAR |
| 2011-01-31 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Mixed | +43,647 | -$251.4K | EDGAR |
| 2011-01-13 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Mixed | +208 | -$964.1K | EDGAR |
| 2011-01-12 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −5,365 | -$193.1K | EDGAR |
| 2011-01-10 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Grant (A) | +50,491 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.